Life Science News

Why Ariad Pharma Is Up Today

Life Science Investing News

Ariad Pharmaceuticals (NASDAQ:ARIA) rose 8.64 percent today after a report said three international pharmaceutical groups are interested in purchasing a controlling stake in the company, The Street reported.

Ariad Pharmaceuticals (NASDAQ:ARIA) rose 8.64 percent today after a report said three international pharmaceutical groups are interested in purchasing a controlling stake in the company, The Street reported.
As quoted in the market news:

The Daily Mail reported that multiple industry majors have been circling Ariad since the Food and Drug Administration green-lit Ariad’s Ponatinib, a leukemia treatment. The report cited rumors that three international pharma groups, including Eli Lilly (LLY_), have made “friendly approaches” to Ariad and are prepared to offer as much as $20 a share to gain control. Other companies mentioned in the report include GlaxoSmithKline (GSK_) and Shire.

Read the full article by The Street

MARKETS

Markets
TSX19857.07+42.56
TSXV586.68+4.79
DOW33517.65-112.96
S&P 5003892.09-2.99
NASD10635.65+66.36
ASX7109.60+46.00

COMMODITIES

Commodities
Gold1871.71+2.31
Silver23.65-0.35
Copper4.01+0.10
Palladium1713.170.00
Platinum1087.260.00
Oil74.87+1.10
Heating Oil3.04+0.03
Natural Gas3.90+0.19

DOWNLOAD FREE REPORTS

×